BBIO

BridgeBio Pharma, Inc.

HealthcareBiotechnologyUSUSDPeers →

$66.80

LiveJun 12, 2026

Market cap

$13.08B

52w range

39.63 – 84.94

P / E

—

EPS · FY 2025

$-3.79

Volume

1.55M

Revenue · FY 2025

$502.08M

+126.26% YoY

Explain this page

Arphra AIPlain-English read on BridgeBio Pharma, Inc.’s valuation

○

Sell-side estimates and price targets skew heavily to US large-caps. We don't have consensus data for this issuer yet.